← Leaderboards
Kerry Jean Koller
Quadriga Biosciences, Inc.
$1,986,820
Attributed
$1,986,820
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2017–18$2M$1.5M$1M$500K$0
'17
'18
Funding mix
By agency
NIH$1,986,820 · 1
By mechanism
R44$1,986,820 · 1
Top collaborators
No co-investigators on record.
Most similar at Quadriga Biosciences, Inc.
Same institution · by research overlap
- Gordon M Ringold$6,041,839
Others in their field
Other Emerging Leaders on “Alkylating Agents”
- Elizabeth Ann Sugar · Johns Hopkins University$4,502,229
- Sunil Kannanganat Sidharthan · Astero Erado Inc$2,898,618
- Edward Thomas Chouchani · Dana-Farber Cancer Inst$2,496,633
- Gordon M Ringold · Quadriga Biosciences, Inc.$2,042,076
- Johan Skog · Massachusetts General Hospital$1,992,445
- Christo Sevov · Ohio State University$1,879,184
Research focus
Alkylating AgentsAdverse EffectsAmino Acid Transport System LAnimal ModelAnimalsAmino AcidsAnticancer ResearchAntineoplastic AgentsApplications GrantsAstrocytesAutopsyAutoradiographyBaseBehaviorBiodistributionBiological MarkersBiomarker IdentificationBlood - Brain Barrier AnatomyBone MarrowBrainBrain NeoplasmsBrain TissueCancer CellCancer Cell Line